86 related articles for article (PubMed ID: 3144959)
1. Endothelial cell proliferation in vitro after incubation with anticoagulant and antiplatelet drugs.
Lindblad B; Wright SW; Burkel WE; Wakefield TW; Graham LM; Sell R; Stanley JC
Artery; 1988; 16(1):15-24. PubMed ID: 3144959
[TBL] [Abstract][Full Text] [Related]
2. Effect of anticoagulant and antiplatelet drugs on in vitro smooth muscle cell proliferation.
Lindblad B; Burkel WE; Graham LM; Darvishian D; Harrell K; Sell R; Stanley JC
Artery; 1988; 15(4):225-33. PubMed ID: 3408349
[TBL] [Abstract][Full Text] [Related]
3. Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins.
Hämmerle H; Betz E; Herr D
Vasa; 1991; 20(3):207-15. PubMed ID: 1659056
[TBL] [Abstract][Full Text] [Related]
4. Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells.
Martinez-Sales V; Vila V; Réganon E; Oms JG; Aznar J
Haematologica; 2003 Jun; 88(6):694-9. PubMed ID: 12801846
[TBL] [Abstract][Full Text] [Related]
5. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.
Khorana AA; Sahni A; Altland OD; Francis CW
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2110-5. PubMed ID: 12920044
[TBL] [Abstract][Full Text] [Related]
6. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Harada N; Okajima K; Uchiba M
Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
[TBL] [Abstract][Full Text] [Related]
7. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
Vignoli A; Marchetti M; Balducci D; Barbui T; Falanga A
Haematologica; 2006 Feb; 91(2):207-14. PubMed ID: 16461305
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic drugs in vascular medicine: a historical perspective.
Schrör K
Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
[TBL] [Abstract][Full Text] [Related]
11. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
Hansen JB; Svensson B; Olsen R; Ezban M; Osterud B; Paulssen RH
Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
[TBL] [Abstract][Full Text] [Related]
12. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
Xue L; Shireman PK; Hampton B; Burgess WH; Greisler HP
J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
[TBL] [Abstract][Full Text] [Related]
13. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
14. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
Maddineni J; Jeske WP; Baltasar F; Cornelli U; Manoni M; Hoppensteadt DA; Fareed J
Clin Appl Thromb Hemost; 2006 Jul; 12(3):311-7. PubMed ID: 16959684
[TBL] [Abstract][Full Text] [Related]
16. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.
Collen A; Smorenburg SM; Peters E; Lupu F; Koolwijk P; Van Noorden C; van Hinsbergh VW
Cancer Res; 2000 Nov; 60(21):6196-200. PubMed ID: 11085545
[TBL] [Abstract][Full Text] [Related]
17. SR 25989 inhibits healing of a mechanical wound of confluent human saphenous vein endothelial cells which is modulated by standard heparin and growth factors.
Klein-Soyer C; Cazenave JP; Herbert JM; Maffrand JP
J Cell Physiol; 1994 Aug; 160(2):316-22. PubMed ID: 7518823
[TBL] [Abstract][Full Text] [Related]
18. Action of dipyridamole and warfarin on growth of human endothelial cells cultured in serum-free media.
Liem LK; Choong LH; Woo KT
Clin Biochem; 2001 Mar; 34(2):141-7. PubMed ID: 11311224
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the intestinal response to ionizing radiation by anticoagulant and non-anticoagulant heparins.
Wang J; Zheng H; Qiu X; Kulkarni A; Fink LM; Hauer-Jensen M
Thromb Haemost; 2005 Nov; 94(5):1054-9. PubMed ID: 16366003
[TBL] [Abstract][Full Text] [Related]
20. Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro.
Westmuckett AD; Kakkar VV; Hamuro T; Lupu F; Lupu C
Thromb Haemost; 2001 Dec; 86(6):1547-54. PubMed ID: 11776326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]